| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.043 | 0.4 |